Relay Therapeutics, Inc. RLAY
- zovegalisib — Breast Cancer Phase 3
- zovegalisib — PIK3CA-Related Overgrowth Spectrum Phase 2
- zovegalisib — Vascular Anomalies Phase 2
PIK3CA (1 companies · 3 programs)
Companies with an active program directed at PIK3CA.